NULIFE SCIENCES, INC.
NULIFE SCIENCES, INC. (NULF): 6 pipeline candidates · ~1 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.6 months
D/E -1.01 · 0% dilution
Lead: Approved
6 candidates
N/A
N/A
A transparent, data-derived signal for NULIFE SCIENCES, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$8K
Quarterly Burn
$83K
Runway
0.6 mo
Revenue
$2K
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (6 candidates)
Frequently asked questions
How many drug candidates are in NULIFE SCIENCES, INC.'s pipeline?
NULIFE SCIENCES, INC. (NULF) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is NULIFE SCIENCES, INC.'s lead drug candidate?
NULIFE SCIENCES, INC.'s most advanced tracked candidate is lyoccp (Preclinical) for Treatment-resistant wounds (specifically diabetic foot ulcers).
What is NULIFE SCIENCES, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, NULIFE SCIENCES, INC. has approximately 0.6 months of cash runway.
Get the full picture on NULIFE SCIENCES, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.